Scanners We Finance
ENT CBCT Scanner Financing
Finance a cone beam CT scanner for your ENT or sinus surgery practice. In-office imaging adds revenue and improves surgical planning. Funding in 1-2 weeks.
Start CT Request →
An ENT practice with in-office cone beam CT completes the diagnostic picture before the patient leaves the exam chair. Sinus anatomy, turbinate hypertrophy, septal deviation, and temporal bone detail come through on a CBCT scan in minutes, and that immediacy changes how cases convert to surgical planning. Sending a patient to a hospital or outpatient imaging center for a dedicated sinus CT breaks the visit-to-decision cycle, introduces scheduling delays, and transfers technical fee revenue to another provider. In-office CBCT puts that revenue and that diagnostic control back in the practice.
ENT-specific cone beam CT units are distinct from dental CBCT units in several clinically meaningful ways. The field of view covers the sinuses, skull base, and temporal bones rather than the dental arches alone, and the positioning system accommodates standing or seated patients for different anatomical regions of interest. A practice considering in-office CBCT should evaluate units designed for ENT applications rather than adapting dental units with limited FOV for paranasal sinus imaging.
We finance ENT CBCT scanners for otolaryngology and ENT practices ranging from solo providers who have reached the referral volume threshold to multi-surgeon practices serving as regional subspecialty centers. Minimum transaction size is $50,000, and most ENT CBCT acquisitions fall landing between $70k and $250k depending on FOV, software platform, and whether the unit includes temporal bone protocol capability.
ENT CBCT System Specifications and What Drives Cost
The following specifications matter most when evaluating an ENT CBCT system and its financing cost:
- Maximum field of view: An FOV covering 17 cm or more in height allows full paranasal sinus imaging plus the skull base in a single acquisition. Smaller FOV units may require repositioning for comprehensive sinus evaluation, which adds to scan time and patient handling complexity.
- Temporal bone protocol capability: High-resolution temporal bone imaging for otologic applications, including cochlear implant planning and cholesteatoma assessment, requires sub-millimeter voxel capability. Not all ENT CBCT units include this, but for practices with a cochlear implant or otology component, it matters significantly.
- Radiation dose: ENT CBCT units designed for sinus applications typically deliver radiation doses well below a standard medical CT of the sinuses, which is a meaningful patient communication point and can influence case acceptance.
- Software integration: Surgical navigation software compatibility and ENT-specific viewing presets are often sold as add-on licenses that belong in the financed total.
For practices that also perform oral and maxillofacial procedures, a unit with combined ENT and dental FOV capability may serve both purposes, though clinical compromises exist in each direction. We also finance dental-focused CBCT units separately when a practice has distinct dental and ENT imaging needs.
Financing Structure for ENT Practices
ENT CBCT transactions typically fall well within the range where application-only financing is available. Without a full financial statement requirement, the approval process for most ENT practices is straightforward and quick. A typical decision comes back within a few business days, and funding follows within one to two weeks of a complete package.
Term lengths of three to five years fit most ENT CBCT acquisitions. A three-year term means the monthly payment is higher but the equipment is fully paid off before it is likely to need significant service attention. A five-year term reduces the monthly obligation and is the right choice for practices that want the payment low enough to be clearly covered by the incremental CBCT technical fee revenue from a modest scan volume.
An equipment finance agreement is the most common structure for ENT CBCT purchases, giving the practice ownership at term end and allowing the full cost to be treated as a capital purchase for depreciation purposes. For the tax treatment benefits, particularly Section 179 expensing in the year of acquisition, the EFA or a capital lease with dollar buyout is the appropriate vehicle.
Practices that want to try a new technology platform without committing to ownership may prefer an operating lease, which gives them the right to return the unit at term end or trade up to a newer system without a residual buyout obligation.
Why In-Office CBCT Has Become a Practice Growth Tool
ENT practices that brought CBCT in-house report several recurring benefits beyond the technical fee revenue. Surgical case conversion rates improve when the patient can see their own anatomy in three dimensions during the consultation rather than relying on a report from an outside imaging center. Same-day diagnosis and surgical planning discussion is simply more compelling than scheduling an outside scan, waiting for the report, then scheduling a follow-up visit to discuss findings.
Rhinology practices performing balloon sinuplasty and functional endoscopic sinus surgery benefit from CBCT planning that shows individual variation in sinus anatomy with detail that two-dimensional X-rays do not provide. Temporal bone surgeons and cochlear implant teams require high-resolution volumetric imaging as a standard of care. A practice that refers those cases out for imaging is giving up both revenue and control of the pre-operative planning workflow.
For practices in markets where hospital outpatient imaging departments are slow to schedule, in-office CBCT also offers a patient service advantage that translates directly to satisfaction and retention. Reducing the number of outside referrals a patient must manage is a quality-of-care improvement that has economic consequences for the practice as well.
The business case for in-office CBCT tends to close quickly for practices doing more than a handful of sinus evaluations and surgical cases per month. We work with practices across markets, from dense urban ENT markets like New York to regional centers where a single ENT practice may be the primary subspecialty resource for a substantial geographic catchment area.
Practices adding an ENT CBCT sometimes discover that the unit also serves allergy and sleep medicine colleagues in the same building, broadening the study mix and the payer diversity of the imaging revenue. A sleep-focused ENT that can perform CBCT airway analysis in-house adds another revenue stream to the unit's utilization profile, improving the per-day scan economics that make the financing payment easy to sustain. We encourage practices to think through the full referral and utilization model, not just the sinus case count, when evaluating the acquisition.
Questions
Can I finance an ENT CBCT unit along with the exam room upgrade and software I need to integrate it into my workflow?
Yes. Software licenses, integration services, and room preparation costs can generally be included in the financed transaction up to the limits of the equipment note. This keeps your capital project on one note with one monthly payment rather than fragmenting costs across multiple purchase orders.
We are a two-surgeon ENT practice and we are not sure our volume justifies a CBCT yet. How do we evaluate whether to finance one?
Look at how many sinus CTs and temporal bone CTs you refer out per month, multiply by the technical fee per study, then compare that annualized number to the annual debt service on the unit you are considering. Most practices find that 10 to 15 ENT CBCT studies per month puts the unit at or near break-even on the financing payment alone, with surgical conversion revenue as upside.
We have a unit we bought three years ago that has a balance remaining. Can we refinance it and get better terms?
Refinancing an existing note is possible, particularly if your credit has improved since the original transaction or if rates and terms have shifted in your favor. We evaluate the remaining balance and current equipment value to determine whether refinancing makes economic sense.
Is the ENT CBCT reimbursed by Medicare and commercial insurance, or is it primarily a self-pay revenue item?
ENT CBCT has established billing codes and is reimbursed by Medicare and commercial payers for covered diagnostic indications including chronic sinusitis evaluation, facial trauma, and cochlear implant candidacy assessment. Reimbursement rates and coverage policies vary by payer and geography, so confirming your market's coverage landscape before the acquisition is worth the conversation with your billing team.
Can a solo ENT provider qualify for financing without a full financial statement package?
For transactions under roughly $400,000, application-only financing is available, meaning we work from credit application data rather than requiring audited financials or extensive documentation. Solo providers qualify through this path regularly.
Talk with the CT desk
Request an ENT CBCT Financing Quote
Tell us the unit you are evaluating, your practice type, and your approximate acquisition timeline. Most ENT CBCT transactions have a decision back within a few days and funding ready within two weeks. New and used equipment both qualify.
